MR1-M3Ade tetramer+, CD3+ T cells within tumor-infiltrating lymphocytes (TILs) from two NSCLC patients (patients 840 and 895) after in vitro expansion. The percentage of MR1-M3Ade tetramer-positive T cells within total CD3+ cells is displayed (left). Right panels show the expression of the CD4 and CD8 markers within MR1-M3Ade tetramer-positive T cells. Numbers in quadrants indicate the percentage of each population calculated on total CD3+, MR1-M3Ade tetramer-positive cells.
